BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

189 related articles for article (PubMed ID: 22253131)

  • 1. Arachidonate 5 lipoxygenase expression in papillary thyroid carcinoma promotes invasion via MMP-9 induction.
    Kummer NT; Nowicki TS; Azzi JP; Reyes I; Iacob C; Xie S; Swati I; Darzynkiewicz Z; Gotlinger KH; Suslina N; Schantz S; Tiwari RK; Geliebter J
    J Cell Biochem; 2012 Jun; 113(6):1998-2008. PubMed ID: 22253131
    [TBL] [Abstract][Full Text] [Related]  

  • 2. FoxM1 and its association with matrix metalloproteinases (MMP) signaling pathway in papillary thyroid carcinoma.
    Ahmed M; Uddin S; Hussain AR; Alyan A; Jehan Z; Al-Dayel F; Al-Nuaim A; Al-Sobhi S; Amin T; Bavi P; Al-Kuraya KS
    J Clin Endocrinol Metab; 2012 Jan; 97(1):E1-E13. PubMed ID: 22049175
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Expression of TGF-β1, SNAI1 and MMP-9 is associated with lymph node metastasis in papillary thyroid carcinoma.
    Wang N; Jiang R; Yang JY; Tang C; Yang L; Xu M; Jiang QF; Liu ZM
    J Mol Histol; 2014 Aug; 45(4):391-9. PubMed ID: 24276590
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Expression of matrix metalloproteinase-2 and its tissue inhibitor-2 in fetal and neoplastic thyroid tissue and their significance as diagnostic and prognostic markers in papillary carcinoma.
    Marečko I; Cvejić D; Tatić S; Dragutinović V; Paunović I; Savin S
    Cancer Biomark; 2011-2012; 11(1):49-58. PubMed ID: 22820140
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Activation of the ROCK1/MMP-9 pathway is associated with the invasion and poor prognosis in papillary thyroid carcinoma.
    Luo D; Chen H; Li X; Lu P; Long M; Peng X; Lin S; Tan L; Zhu Y; Ouyang N; Li H
    Int J Oncol; 2017 Oct; 51(4):1209-1218. PubMed ID: 28848996
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Protein expression of matrix metalloproteinases 2 and 9 and tissue inhibitors of metalloproteinase 1 and 2 in papillary thyroid carcinomas.
    Maeta H; Ohgi S; Terada T
    Virchows Arch; 2001 Feb; 438(2):121-8. PubMed ID: 11253113
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Immunohistochemical levels of cyclo-oxygenase-2, matrix metalloproteinase-9 and vascular endothelial growth factor in papillary thyroid carcinoma and their clinicopathological correlations.
    Meng XY; Zhang Q; Li Q; Lin S; Li J
    J Int Med Res; 2014 Jun; 42(3):619-27. PubMed ID: 24670538
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Coexpressed High Levels of VEGF-C and Active MMP-9 Are Associated With Lymphatic Spreading and Local Invasiveness of Papillary Thyroid Carcinoma.
    Šelemetjev S; Ðoric I; Paunovic I; Tatic S; Cvejic D
    Am J Clin Pathol; 2016 Nov; 146(5):594-602. PubMed ID: 27806941
    [TBL] [Abstract][Full Text] [Related]  

  • 9. [Expression of matrix metalloproteinases 2 and 9 and their tissue inhibitors 1 and 2 in papillary thyroid cancer: an association with the clinical, morphological and ultrastructural characteristics of a tumor].
    Delektorskaia VV; Smirnova EA; Ponomareva MV; Pavlova TV; Pavlov IA
    Arkh Patol; 2010; 72(4):3-6. PubMed ID: 21086628
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Expression of the membrane mucins MUC4 and MUC15, potential markers of malignancy and prognosis, in papillary thyroid carcinoma.
    Nam KH; Noh TW; Chung SH; Lee SH; Lee MK; Hong SW; Chung WY; Lee EJ; Park CS
    Thyroid; 2011 Jul; 21(7):745-50. PubMed ID: 21615302
    [TBL] [Abstract][Full Text] [Related]  

  • 11. MiRNA-146b-5p upregulates migration and invasion of different Papillary Thyroid Carcinoma cells.
    Lima CR; Geraldo MV; Fuziwara CS; Kimura ET; Santos MF
    BMC Cancer; 2016 Feb; 16():108. PubMed ID: 26883911
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Urokinase receptor, MMP-1 and MMP-9 are markers to differentiate prognosis, adenoma and carcinoma in thyroid malignancies.
    Buergy D; Weber T; Maurer GD; Mudduluru G; Medved F; Leupold JH; Brauckhoff M; Post S; Dralle H; Allgayer H
    Int J Cancer; 2009 Aug; 125(4):894-901. PubMed ID: 19480010
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Long noncoding RNA HIT000218960 promotes papillary thyroid cancer oncogenesis and tumor progression by upregulating the expression of high mobility group AT-hook 2 (HMGA2) gene.
    Li T; Yang XD; Ye CX; Shen ZL; Yang Y; Wang B; Guo P; Gao ZD; Ye YJ; Jiang KW; Wang S
    Cell Cycle; 2017 Jan; 16(2):224-231. PubMed ID: 27929737
    [TBL] [Abstract][Full Text] [Related]  

  • 14. LncRNA HOTTIP promotes papillary thyroid carcinoma cell proliferation, invasion and migration by regulating miR-637.
    Yuan Q; Liu Y; Fan Y; Liu Z; Wang X; Jia M; Geng Z; Zhang J; Lu X
    Int J Biochem Cell Biol; 2018 May; 98():1-9. PubMed ID: 29474928
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Enhanced activation of matrix metalloproteinase-9 correlates with the degree of papillary thyroid carcinoma infiltration.
    Marecko I; Cvejic D; Selemetjev S; Paskas S; Tatic S; Paunovic I; Savin S
    Croat Med J; 2014 Apr; 55(2):128-37. PubMed ID: 24778099
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Downregulation of uPAR inhibits migration, invasion, proliferation, FAK/PI3K/Akt signaling and induces senescence in papillary thyroid carcinoma cells.
    Nowicki TS; Zhao H; Darzynkiewicz Z; Moscatello A; Shin E; Schantz S; Tiwari RK; Geliebter J
    Cell Cycle; 2011 Jan; 10(1):100-7. PubMed ID: 21191179
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Cancer-educated neutrophils promote lung cancer progression
    Han L; Chen Y; Huang N; Zhou X; Lv Y; Li H; Chai D; Zheng J; Wang G
    Cancer Biol Med; 2024 Jan; 21(2):175-92. PubMed ID: 38172525
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Expression of MMP-13 is associated with invasion and metastasis of papillary thyroid carcinoma.
    Wang JR; Li XH; Gao XJ; An SC; Liu H; Liang J; Zhang K; Liu Z; Wang J; Chen Z; Sun W
    Eur Rev Med Pharmacol Sci; 2013 Feb; 17(4):427-35. PubMed ID: 23467939
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Gene expression profiling identifies potential molecular markers of papillary thyroid carcinoma.
    Reyes I; Reyes N; Suriano R; Iacob C; Suslina N; Policastro A; Moscatello A; Schantz S; Tiwari RK; Geliebter J
    Cancer Biomark; 2019; 24(1):71-83. PubMed ID: 30614796
    [TBL] [Abstract][Full Text] [Related]  

  • 20. miRNA-21 promotes cell proliferation and invasion via VHL/PI3K/AKT in papillary thyroid carcinoma.
    Zang C; Sun J; Liu W; Chu C; Jiang L; Ge R
    Hum Cell; 2019 Oct; 32(4):428-436. PubMed ID: 31161410
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 10.